- Enterprise.
- Not disclosed
- Not disclosed
- —
- —
- US
Mammography CAD (cmTriage, cmAssist).
Free tier available.
US mammography CAD vendor.
What it costs
Free tier only; no paid plans publicly disclosed.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | — | — | Enterprise. |
Source: vendor pricing page. Verified May 23, 2026.
What the literature says
3 peer-reviewed studies indexed on PubMed evaluate CureMetrix in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events.
- Nerlekar N, Soh CH, Vasanthakumar S, et al.· JACC Cardiovasc Imaging· 2026
- Breast arterial calcification (BAC) detected on routine mammography is an emerging marker of cardiovascular risk in women. However, substantial age-related variability limits its clinical interpretability. Age-adjusted nomograms may improve risk stratification and communication. This study aims to determine whether age-adjusted BAC percentiles derived from mammography predict major adverse cardiovascular events (MACE) independent of atherosclerotic cardiovascular disease (ASCVD) risk scores. In this multicenter retrospective cohort study, 21,514 women without known cardiovascular disease and…
- Evaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital Mammography.
- Arce S, Vijay A, Yim E, et al.· Cureus· 2023
- Introduction Early breast cancer detection with screening mammography has been shown to reduce mortality and improve breast cancer survival. This study aims to evaluate the ability of an artificial intelligence computer-aided detection (AI CAD) system to detect biopsy-proven invasive lobular carcinoma (ILC) on digital mammography. Methods This retrospective study reviewed mammograms of patients who were diagnosed with biopsy-proved ILC between January 1, 2017, and January 1, 2022. All mammograms were analyzed using cmAssist(CureMetrix, San Diego, California, United States), which is an AI CAD…
- Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage.
- Retson TA, Watanabe AT, Vu H, et al.· J Breast Imaging· 2022Observational
- Artificial intelligence (AI)-based triage algorithms may improve cancer detection and expedite radiologist workflow. To this end, the performance of a commercial AI-based triage algorithm on screening mammograms was evaluated across breast densities and lesion types. This retrospective, IRB-exempt, multicenter, multivendor study examined 1255 screening 4-view mammograms (400 positive and 855 negative studies). Images were anonymized by providing institutions and analyzed by a commercially available AI algorithm (cmTriage, CureMetrix, La Jolla, CA) that performed retrospective triage at the st…
Other radiology
See the full radiology ranking
Siemens Healthineers AI-Rad Companion
by Siemens Healthineers
AI-Rad Companion suite (chest, cardiac, prostate) plus Varian.
Enterprise + OEM.|FDA 510(k) (multiple) / CE-IVDR
GE HealthCare AI Suite
by GE HealthCare
Largest radiology AI portfolio (120+ FDA clearances).
Enterprise + OEM-bundled.|FDA 510(k) (multiple) / CE-IVDR
Aidoc
by Aidoc
Acute-care triage aiOS platform, 31+ FDA clearances, 1,000+ sites.
Enterprise (~$50k+/site/yr baseline, module-based).|FDA 510(k) (multiple) / CE-IVDR
Viz.ai
by Viz.ai
Stroke + cardio + PE coordination platform, 1,700+ hospitals.
Enterprise (per-site subscription).|FDA 510(k) (multiple) / HIPAA